Han JW - Search Results

1

Tissue-Resident Lymphocytes: Implications in Immunotherapy for Hepatocellular Carcinoma.

Han JW, Yoon SK. Han JW, et al. Int J Mol Sci. 2020 Dec 28;22(1):232. doi: 10.3390/ijms22010232. Int J Mol Sci. 2020. PMID: 33379384 Free PMC article. Review.

2

Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen negative patients with hematological malignancies.

Han JW, Yang H, Lee HL, Bae SH, Choi JY, Lee JW, Kim HJ, Lee S, Cho SG, Min CK, Kim DW, Yoon SK. Han JW, et al. Hepatol Res. 2016 Jun;46(7):657-68. doi: 10.1111/hepr.12603. Epub 2015 Nov 5. Hepatol Res. 2016. PMID: 26445232

3

Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases.

Jang B, Han JW, Sung PS, Jang JW, Bae SH, Choi JY, Cho YI, Yoon SK. Jang B, et al. Among authors: han jw. J Korean Med Sci. 2016 Dec;31(12):1943-1948. doi: 10.3346/jkms.2016.31.12.1943. J Korean Med Sci. 2016. PMID: 27822933 Free PMC article.

4

A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function.

Yang H, Woo HY, Lee SK, Han JW, Jang B, Nam HC, Lee HL, Lee SW, Song DS, Song MJ, Oh JS, Chun HJ, Jang JW, Lozada A, Bae SH, Choi JY, Yoon SK. Yang H, et al. Among authors: han jw. Clin Mol Hepatol. 2017 Jun;23(2):128-137. doi: 10.3350/cmh.2016.0071. Epub 2017 May 10. Clin Mol Hepatol. 2017. PMID: 28494528 Free PMC article.

5

Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B.

Lee HL, Jang JW, Han JW, Lee SW, Bae SH, Choi JY, Han NI, Yoon SK, Kim HJ, Lee S, Cho SG, Min CK, Kim DW, Lee JW. Lee HL, et al. Among authors: han ni, han jw. Dig Dis Sci. 2019 Oct;64(10):2992-3000. doi: 10.1007/s10620-019-05614-6. Epub 2019 Apr 13. Dig Dis Sci. 2019. PMID: 30982209

6

Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8⁺ T Cells in Patients Considered Immune Tolerant.

Sung PS, Park DJ, Kim JH, Han JW, Lee EB, Lee GW, Nam HC, Jang JW, Bae SH, Choi JY, Shin EC, Park SH, Yoon SK. Sung PS, et al. Among authors: han jw. Front Immunol. 2019 Jun 6;10:1319. doi: 10.3389/fimmu.2019.01319. eCollection 2019. Front Immunol. 2019. PMID: 31244857 Free PMC article.

7

Liver-Resident Memory CD8⁺ T Cells: Possible Roles in Chronic HBV Infection.

Han JW, Shin EC. Han JW, et al. Int J Mol Sci. 2020 Dec 30;22(1):283. doi: 10.3390/ijms22010283. Int J Mol Sci. 2020. PMID: 33396596 Free PMC article. Review.

8

Distinct Patterns of HBV Integration and TERT Alterations between in Tumor and Non-Tumor Tissue in Patients with Hepatocellular Carcinoma.

Jang JW, Kim HS, Kim JS, Lee SK, Han JW, Sung PS, Bae SH, Choi JY, Yoon SK, Han DJ, Kim TM, Roberts LR. Jang JW, et al. Among authors: han dj, han jw. Int J Mol Sci. 2021 Jun 30;22(13):7056. doi: 10.3390/ijms22137056. Int J Mol Sci. 2021. PMID: 34209079 Free PMC article.

9

Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant.

Sung PS, Han JW, Seo C, Ahn J, Lee SK, Nam HC, Choi HJ, You YK, Jang JW, Choi JY, Yoon SK. Sung PS, et al. Among authors: han jw. Front Pharmacol. 2021 Jul 13;12:685176. doi: 10.3389/fphar.2021.685176. eCollection 2021. Front Pharmacol. 2021. PMID: 34326770 Free PMC article.

10

Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy.

Han JW, Yoon SK. Han JW, et al. Pharmaceutics. 2021 Sep 2;13(9):1387. doi: 10.3390/pharmaceutics13091387. Pharmaceutics. 2021. PMID: 34575463 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,119 results

Search Page